Oral Delivery of Pterostilbene by L-Arginine-Mediated “Nano-Bomb” Carrier for the Treatment of Ulcerative Colitis

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) of unknown aetiology affecting the colon and rectum. Pterostilbene (PS) has been reported as an effective antioxidant and anti-inflammatory agent in preclinical IBD models. However, the therapeutic outcomes of PS are l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Zhang, Yujie, Li, Runqing, Cao, Yameng, Yan, Xiangji, Ma, Yana, Zhang, Yuanyuan, Yang, Mei, Zhang, Mingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843770/
https://www.ncbi.nlm.nih.gov/pubmed/35177902
http://dx.doi.org/10.2147/IJN.S347506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843770/
https://www.ncbi.nlm.nih.gov/pubmed/35177902
http://dx.doi.org/10.2147/IJN.S347506

Ejemplares similares